|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,018.00 GBX | -1.57% |
|
-1.60% | +0.27% |
| 16/01 | BofA cuts British Land; RBC raises Gym Group | AN |
| 16/01 | China revs up fiscal support to boost births | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.4TCr | 1.32TCr | 1.45TCr | 1.46TCr | 1.42TCr | |||||
Total Revenues | 1.4TCr | 1.32TCr | 1.45TCr | 1.46TCr | 1.42TCr | |||||
Cost of Goods Sold, Total | 555.8Cr | 554.4Cr | 609.2Cr | 584.7Cr | 557.4Cr | |||||
Gross Profit | 843.5Cr | 769Cr | 836.1Cr | 876Cr | 859.5Cr | |||||
Selling General & Admin Expenses, Total | 500.4Cr | 465Cr | 468.4Cr | 510.7Cr | 499.3Cr | |||||
R&D Expenses | 29Cr | 31Cr | 32Cr | 34Cr | 32Cr | |||||
Other Operating Expenses | -20L | -30L | -90L | -30L | -17Cr | |||||
Other Operating Expenses, Total | 529Cr | 496Cr | 500Cr | 544.1Cr | 514.6Cr | |||||
Operating Income | 314.5Cr | 273Cr | 336.1Cr | 331.9Cr | 344.9Cr | |||||
Interest Expense, Total | -28Cr | -24Cr | -23Cr | -30Cr | -39Cr | |||||
Interest And Investment Income | 6.1Cr | 2.9Cr | 2.9Cr | 4.1Cr | 5.3Cr | |||||
Net Interest Expenses | -22Cr | -22Cr | -20Cr | -25Cr | -34Cr | |||||
Income (Loss) On Equity Invest. | -10L | -30L | -20L | - | - | |||||
Currency Exchange Gains (Loss) | - | 76Cr | -3.7Cr | 1.5Cr | -1.3Cr | |||||
Other Non Operating Income (Expenses) | -7.1Cr | -40L | -70L | -3.5Cr | 1.4Cr | |||||
EBT, Excl. Unusual Items | 285.8Cr | 327.2Cr | 311.1Cr | 304.5Cr | 311Cr | |||||
Restructuring Charges | - | - | - | - | -17Cr | |||||
Merger & Related Restructuring Charges | - | -1.4Cr | - | - | - | |||||
Impairment of Goodwill | -98Cr | - | -17Cr | -81Cr | -70Cr | |||||
Gain (Loss) On Sale Of Investments | - | - | -1.9Cr | - | - | |||||
Gain (Loss) On Sale Of Assets | - | -351.8Cr | 14Cr | 17Cr | - | |||||
Asset Writedown | - | - | - | - | -14Cr | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 187.3Cr | -26Cr | 306.7Cr | 240.1Cr | 210.4Cr | |||||
Income Tax Expense | 72Cr | -21Cr | 71Cr | 75Cr | 67Cr | |||||
Earnings From Continuing Operations | 115.3Cr | -5.2Cr | 235.6Cr | 164.8Cr | 143.2Cr | |||||
Earnings Of Discontinued Operations | 5Cr | 3.1Cr | -70L | 90L | -40L | |||||
Net Income to Company | 120.3Cr | -2.1Cr | 234.9Cr | 165.7Cr | 142.8Cr | |||||
Minority Interest | -1.6Cr | -1.1Cr | -1.9Cr | -1.4Cr | -20L | |||||
Net Income - (IS) | 118.7Cr | -3.2Cr | 233Cr | 164.3Cr | 142.6Cr | |||||
Net Income to Common Incl Extra Items | 118.7Cr | -3.2Cr | 233Cr | 164.3Cr | 142.6Cr | |||||
Net Income to Common Excl. Extra Items | 113.7Cr | -6.3Cr | 233.7Cr | 163.4Cr | 143Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.67 | -0.04 | 3.26 | 2.29 | 2.04 | |||||
Basic EPS - Continuing Operations | 1.6 | -0.09 | 3.27 | 2.28 | 2.04 | |||||
Basic Weighted Average Shares Outstanding | 71Cr | 71Cr | 72Cr | 72Cr | 70Cr | |||||
Net EPS - Diluted | 1.66 | -0.04 | 3.25 | 2.29 | 2.03 | |||||
Diluted EPS - Continuing Operations | 1.59 | -0.09 | 3.26 | 2.27 | 2.04 | |||||
Diluted Weighted Average Shares Outstanding | 71Cr | 71Cr | 72Cr | 72Cr | 70Cr | |||||
Normalized Basic EPS | 2.49 | 2.85 | 2.69 | 2.64 | 2.77 | |||||
Normalized Diluted EPS | 2.48 | 2.85 | 2.68 | 2.63 | 2.77 | |||||
Dividend Per Share | 1.75 | 1.75 | 1.83 | 1.92 | 2.02 | |||||
Payout Ratio | 104.55 | -3.89T | 53.61 | 81.5 | 96.84 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 348Cr | 302.2Cr | 364.7Cr | 361.4Cr | 374.6Cr | |||||
EBITA | 323.3Cr | 279.6Cr | 340.1Cr | 334.7Cr | 347.8Cr | |||||
EBIT | 314.5Cr | 273Cr | 336.1Cr | 331.9Cr | 344.9Cr | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 38.44 | 80 | 23.18 | 31.36 | 31.94 | |||||
Total Current Taxes | 70Cr | 76Cr | 74Cr | 80Cr | 70Cr | |||||
Total Deferred Taxes | 2.5Cr | -97Cr | -3.2Cr | -5.2Cr | -2.8Cr | |||||
Normalized Net Income | 177.02Cr | 203.4Cr | 192.54Cr | 188.91Cr | 194.18Cr | |||||
Interest on Long-Term Debt | 1.3Cr | 1.3Cr | 1.6Cr | 1.4Cr | 1.3Cr | |||||
Non-Cash Pension Expense | -50L | 30L | -60L | -60L | -60L | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | - | - | - | 216.2Cr | |||||
Selling and Marketing Expenses | 361.1Cr | 346Cr | 343.8Cr | 370.3Cr | 353.7Cr | |||||
General and Administrative Expenses | 139.3Cr | 119Cr | 125.1Cr | 141.2Cr | 146.1Cr | |||||
Research And Development Expense From Footnotes | 29Cr | 31Cr | 32Cr | 34Cr | 32Cr | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 1.5Cr | 3Cr | 7.8Cr | 10Cr | 8.5Cr | |||||
Total Stock-Based Compensation | 1.5Cr | 3Cr | 7.8Cr | 10Cr | 8.5Cr |
- Stock Market
- Equities
- RB. Stock
- Financials Reckitt Benckiser Group plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















